Image source: Canva Around 20,000 Americans are affected by acute myeloid leukemia (AML) each year. AML is a type of cancer that originates in the bone marrow and rapidly enters the bloodstream. Additionally, many individuals are impacted by myelodysplastic syndromes (MDS), which are blood disorders that result in the improper formation or functioning of blood … Continue reading CIRM awards $8 million to Support Groundbreaking Gene Therapy for AML and MDS
How the Strategic Allocation Framework (SAF) Impacts the Future of CIRM’s Research Funding
At the California Institute for Regenerative Medicine (CIRM), our mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. For nearly two decades, CIRM has been at the forefront of the regenerative medicine field, catalyzing significant scientific breakthroughs and developing therapies that … Continue reading How the Strategic Allocation Framework (SAF) Impacts the Future of CIRM’s Research Funding
CIRM $4 million awarded to support innovative Gene Therapy for Rare Heart Disorder
Image Source: American Heart Association Journals The California Institute for Regenerative Medicine (CIRM) recently awarded $4 million to support the development of a one-time gene therapy for desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM), a rare and life-threatening genetic disorder. This preclinical award to Deborah D. Ascheim, MD, and her team at Rejuvenate Bio are … Continue reading CIRM $4 million awarded to support innovative Gene Therapy for Rare Heart Disorder
CIRM awards $26 million to boost clinical trials for cancer, heart, and rare diseases
The California Institute for Regenerative Medicine (CIRM) is proud to announce the allocation of $26 million to support clinical research targeting a range of cancers, heart conditions, and rare diseases. This significant funding underscores CIRM’s commitment to advancing innovative stem cell and gene therapy-based treatments through all stages of clinical trial development. This latest round … Continue reading CIRM awards $26 million to boost clinical trials for cancer, heart, and rare diseases
Turning Hope into Reality: How a Genetic Therapy Helped Connor
Photo credit: n-Lorem Connor Dalby is a 15-year-old teenager who loves music and the beach, but his journey has been far from ordinary. Diagnosed with a rare mutation in the SCN2A gene, his life has been filled with challenges. From the time he was just a few weeks old, he had trouble sleeping and struggled … Continue reading Turning Hope into Reality: How a Genetic Therapy Helped Connor
Next Generation of Regenerative Medicine Scientists and the Golden Era of Biomedical Innovation
CIRM CEO and President, Jonathan 'JT' Thomas speaking in front of conference attendees. During the first-ever California Institute for Regenerative Medicine (CIRM) Trainee Networking Conference, more than 400 students and postdoctoral fellows from CIRM's Bridges, COMPASS, and Scholars programs gathered from different parts of California for a three-day event at the University of Southern California … Continue reading Next Generation of Regenerative Medicine Scientists and the Golden Era of Biomedical Innovation
Where Are They Now: Jake Javier
The California Institute for Regenerative Medicine (CIRM) in partnership with the University of Southern California (USC) recently hosted the 2024 CIRM Trainee Network Conference, which provided trainees from CIRM’s education and training programs an opportunity to engage with patient advocates and other professionals in the field. On the first day, Jake Javier took the stage … Continue reading Where Are They Now: Jake Javier
A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
At the California Institute for Regenerative Medicine (CIRM), we enjoy highlighting achievements that come out of the research we support. We recently sat down with Cory Nicholas, PhD, CEO and Co-Founder of Neurona Therapeutics, to discuss an important milestone for the clinical-stage company. Neurona recently received the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation for … Continue reading A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
California high schoolers “ignite innovation” at 2024 SPARK conference
More than 100 student scientists from around California showcased their excitement for regenerative medicine and stem cell research at this year’s annual CIRM SPARK Conference in the sunny Inland Empire. Hosted by UC Riverside from Aug. 5-6 at the Riverside Convention Center, this year’s event showcased the extraordinary talent and enthusiasm of high school students … Continue reading California high schoolers “ignite innovation” at 2024 SPARK conference
Ready, set, pitch!
The California Institute for Regenerative Medicine (CIRM) funds and provides valuable educational and training opportunities in regenerative medicine for students and young professionals from backgrounds that reflect the diverse communities across California. One of the goals of these work training programs is to inspire the next generation of regenerative medicine scientists. CIRM does that by … Continue reading Ready, set, pitch!
The Stem Cellar 